Navegar por los elementos (20655 total)

A novel coronavirus (nCoV) was first identified amid a recent outbreak of respiratory disease cases in China, Wuhan City. This infection was initially reported to the World Health Organization (WHO) on December 31, 2019. One month later, the WHO…

The epidemic of the SARS-CoV-2 infection has presented as a critical period. Until February 14th 2020, more than 55 000 cases of SARS-CoV-2 infection has been confirmed in China, which has a great impact on economy and society, and also seriously…

The virus, called COVID-19, which has emerged in China in December 2019, has been known to spread through droplets and close contact, and has evolved into a pandemic today. It is also known that in all patients who have come into contact with…

At present, the new coronavirus(COVID-19)epidemic is spreading rapidly in Wuhan city Hubei province of China, and has aroused great attention of the international community. There have been clues that the conjunctiva may be one of the entries for the…

Infecţíile virale de tract respirator reprezintă una din cauzele principale de morbiditate şi mortalitate în patologiapediatrică. Autorii aduc informaţii de ultima oră privind structura, mecanismele patogenetice, caracteristicilecli nice,…

SARS-CoV-2 has been spreading rapidly since its outbreak in December 2019.Understanding its epidemiological characteristics, especially cutting off transmission routes, is crucial to controlling the spread of the disease. In the study of transmission…

Coronavirus disease 2019 (COVID-19) outbreak started in December 2019 that caused difficulties for clinical work. Practical work experience in our spinal outpatient and emergency department during the COVID-19 pandemic is summarized in this article,…

The novel coronavirus, which was called 2019-nCoV at the beginning of the outbreak, was named SARS-CoV-2 later. The clinical disease caused by the virus was also called Coronavirus disease 2019 (COVID-19). World Health Organization declared COVID-19…

BACKGROUND:Host responses to viral infection include both immune activation and programmed cell death. The mitochondrial antiviral signaling adaptor, MAVS (IPS-1, VISA or Cardif) is critical for host defenses to viral infection by inducing type-1…